iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Purchased by Values First Advisors Inc.

Values First Advisors Inc. raised its position in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 9.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 5,588 shares of the company’s stock after buying an additional 467 shares during the quarter. Values First Advisors Inc.’s holdings in iRhythm Technologies were worth $504,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. State Street Corp increased its stake in shares of iRhythm Technologies by 1.3% during the third quarter. State Street Corp now owns 908,843 shares of the company’s stock worth $67,473,000 after acquiring an additional 11,992 shares during the period. Braidwell LP lifted its position in iRhythm Technologies by 48.7% in the third quarter. Braidwell LP now owns 782,557 shares of the company’s stock valued at $58,097,000 after purchasing an additional 256,200 shares during the period. Eventide Asset Management LLC boosted its holdings in iRhythm Technologies by 170.8% in the 3rd quarter. Eventide Asset Management LLC now owns 736,721 shares of the company’s stock valued at $54,694,000 after purchasing an additional 464,629 shares in the last quarter. Geode Capital Management LLC increased its position in iRhythm Technologies by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 733,308 shares of the company’s stock worth $54,451,000 after purchasing an additional 5,423 shares during the period. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its stake in shares of iRhythm Technologies by 38.1% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 707,175 shares of the company’s stock worth $52,501,000 after buying an additional 195,246 shares in the last quarter.

Insider Buying and Selling

In related news, insider Patrick Michael Murphy sold 2,492 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $85.89, for a total transaction of $214,037.88. Following the sale, the insider now owns 35,327 shares of the company’s stock, valued at $3,034,236.03. This trade represents a 6.59 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.68% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on IRTC. Truist Financial lifted their price target on iRhythm Technologies from $85.00 to $111.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. Robert W. Baird reduced their target price on iRhythm Technologies from $100.00 to $79.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Needham & Company LLC upped their price target on shares of iRhythm Technologies from $96.00 to $112.00 and gave the stock a “buy” rating in a research note on Monday, January 13th. Oppenheimer raised their price objective on shares of iRhythm Technologies from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company restated an “equal weight” rating and set a $86.00 target price on shares of iRhythm Technologies in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $108.45.

iRhythm Technologies Trading Up 4.0 %

Shares of NASDAQ IRTC opened at $111.17 on Thursday. The firm’s 50-day moving average is $97.43 and its two-hundred day moving average is $81.88. iRhythm Technologies, Inc. has a 12-month low of $55.92 and a 12-month high of $124.11. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.